It is our privilege to be working with IntraMed West & Signature Business Solutions on this enriching application as it represents part of our own corporate goals to provide our state of the art rich media technologies to comprehensive E-Learning applications. Mr. Ide added,
Phoenix, AZ (PRWEB) November 20, 2006
Modavox, Inc. (OTCBB: MDVX), Internet broadcasting pioneer, producing and syndicating online audio and video, today announced it has, through partnership with IntraMed West, Inc. and Signature Business Solutions, completed and launched a website for Interventional Radiology Fellows.
IRexcellence.com is the official website of the Pathway to Excellence: Advancing Interventional Radiology education initiative. Guided by a planning committee of interventional radiology thought leaders, IRexcellence.com is dedicated to serving the IR community by providing educational resources, news, information, and an open forum for communication and collaboration.
Modavox Vice President of Business Development & Strategic Marketing, Nathaniel Bradley, stated, “Streaming Media solutions from Modavox provide for dynamic E-Learning communications for Interventional Radiology Fellows.” Modavox CEO David Ide stated, “It is our privilege to be working with IntraMed West & Signature Business Solutions on this enriching application as it represents part of our own corporate goals to provide our state of the art rich media technologies to comprehensive E-Learning applications. Mr. Ide added, “Modavox Interactive continues to provide professional and highly scalable rich media applications we believe create a balanced approach to Modavox's future earnings.”
About IntraMed West
IntraMed West, Inc., a company owned and operated by Sudler & Hennessey, a Young & Rubicam/WPP company, is one of the world's largest and most prestigious health care communication companies.
Founded 30 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes biotherapeutics for significant unmet medical needs. A considerable number of the currently approved biotechnology products originated from or are based on Genentech's science. Genentech manufactures and commercializes multiple biotechnology products and licenses several additional products to other companies. The company has headquarters in South San Francisco, California and is listed on the New York Stock Exchange under the symbol DNA. For additional information about the company, please visit http://www.gene.com.
This release contains “forward-looking statements” for purposes of the Securities and Exchange Commission’s “safe harbor” provisions under the Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under the Securities Exchange Act of 1934. These forward-looking statements are subject to various risks and uncertainties that could cause Modavox’s actual results to differ materially from those currently anticipated, including the risk factors identified in Modavox’s filings with the Securities and Exchange Commission.
# # #